healthprotocol.wiki

safety-treatment-related-grade-3-or-higher-adverse-events-count-cohort-measured

1 evidence row · 1 protocol

Evidence

capitello-281_0000_rct_capitello-281-a-phase-3-study-of-capivasertib-abiraterone-vs-placebo-abiraterone-in-patients-with-pten-deficient-de-novo-metastatic-hormone-sensitive-prostate-cancer

Protocols

medication-cancer-prostate-capivasertib-abiraterone-androgen-deprivation